The present invention relates to novel pyrrole substituted 2-indolinone
compounds and physiologically acceptable salts and prodrugs thereof which
modulate the activity of protein kinases and therefore are expected to be
useful in the prevention and treatment of protein kinase related cellular
disorders such as cancer.